Business

Montec Holdings Inc. announces 2009 first quarter results

MONTREAL, June 2 /CNW Telbec/ - Montec Holdings Inc. ("Montec" or the "Company") (TSX-V : MTE), a...

articleDefence Therapeutics Inc Class AJune 2, 20094/company/defence-therapeutics-inc/news/montec-holdings-inc-announces-2009-first-quarter-results
Montec Holdings Inc. announces 2009 first quarter results

About this update from Defence Therapeutics Inc Class A

[{"type":"text","content":"\n\n\n\nMONTREAL, June 2 /CNW Telbec/ - Montec Holdings Inc. ("Montec" or the\n"Company") (TSX-V : MTE), a holding company focused on acquiring and\ndeveloping a diversified portfolio of high-growth technology companies, today\nannounced its operational and financial results for the three-month period\nended on March 31, 2009.\n\n\n2009 First Quarter Highlights\n\n\n- 23% revenue increase from Q1 2008.\n- Continued to gain traction in the OSS space with increased R&D efforts.\n\n\nMontec Consolidated Interim Financials\n\n\nSales in the first quarter of 2009 totalled $1.6 million, an increase of\n$0.3 million, or 23%, from $1.3 million during the same period in 2008. All\nMontec revenues are generated by its wholly owned subsidiary Datex Billing\nServices Inc.\n\n\nGross margin in the first quarter of 2009 was 46% of sales compared to\n62% during the same period in 2008, due to the product mix; DMS revenues,\nproviding a 24% gross margin, increased by 46%, compared to a decrease of 5%\nin DBS segment, with an 86% gross margin.\n\n\nOperating expenses in the first quarter of 2009 totalled $1.1 million, an\nincrease of $0.1 million from $1.0 million during the same period in 2008.\nThis increase mainly results from investments in research and development\nexpenses, increased sales force to improve customer relations and service for\nanticipated contracts that have been delayed due to the economic downturn.\n\n\nConsolidated net loss and comprehensive loss of the first quarter of 2009\nstood at $320,000, or a basic and diluted net loss per share of $0.006,\ncompared to a net loss of $155,000, or a basic and diluted loss per share of\n$0.007, for the same period in 2008.\n\n\nAs of May 29, 2009, the authorized capital of Montec consisted of an\nunlimited number of Montec Common shares, Series A preferred shares and Series\nB preferred shares of which 49,704,500 Common shares, 7,294,118 Series A\npreferred shares, 1,253,342 options and 3,450,000 common share purchase\nwarrants shall be issued and outstanding. Of these, a total of 1,808,999\ncommon shares, 2,188,238 preferred shares and 909,000 purchase warrants are\nheld in escrow.\n\n\nDuring the first quarter of 2009, Datex Billing Services Inc. entered\ninto an agreement to provide its customer management and billing services to\nMelaleuca Inc. Under the te...

More updates from Defence Therapeutics Inc Class A